Compare Novo Nordisk A/S (NVO) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs SkyWest Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while SkyWest Inc trades at $95.26 (market cap $3.94B). The key difference: Novo Nordisk A/S is far larger — about 56× SkyWest Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while SkyWest Inc pays none. Which is the better fit depends on your goals.
| NVO | SKYW | |
|---|---|---|
Market Cap | $220.53B | $3.94B |
Sector | Health | Technology |
52-Week High | $71.70 | $123.72 |
52-Week Low | $35.29 | $78.40 |
Enterprise Value | $239.49B | $5.79B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
